Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Search Results Your Search for 'Serono SA Deals Briefing' returned 4 results - Page 1 of 1   Sort by    Report Name ASC Report Name DESC Report Price ASC Report Price DESC Rank ASC Rank DESC   Sorted by Rank Top-Bottom Biosimilars: Beyond the first product wave   Espicom Business Intelligence Ltd, Oct 2009, Pages: 218 ... applications rejected by EMEA Bioton SA Cangene Accretropin ... Co Three Rivers Pharmaceuticals Viropro Deal with Intas ... 08 (US$ millions) Merck/Serono HGH Sales ... Biosimilars: A Viable Market - But When?   Espicom Business Intelligence Ltd, Sep 2008, Pages: 210 ... Neose Technologies 149 BioPartners 151 Bioton SA 153 Cangene ... Rivers Pharmaceuticals 192 Viropro 193 Deal with Intas ... 06 (US$ millions) 26 Merck/Serono HGH Sales ... The Neurotechnology Industry 2009 Report   NeuroInsights, May 2009, Pages: 480 ... Partnering and Licensing Deals 2004-Q1 ... Memory Pharmaceuticals - Merck - Merck Serono - Merlin - Merz ... NeuroSync - Neurotech SA - NeuroTherapeutics - NeuroTrax ... Antivirals - Global Strategic Business Report   Global Industry Analysts, Inc., Oct 2006, Pages: 699 ... Ares Serono (France) IV-52 16. ... (South Africa) IV-56 Table 141: Annual Sales Analysis: 2004-2005 (In R million) IV-58 19. ... Biomerieux SA (France) IV-104 29. ... No more results

		Top of page

All rights reserved. © Copyright 2010 Research and Markets1    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster